Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mass balance study of oral [14C]-TEV-56286 in healthy male participants
NL-OMON58700Phase 1Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of emrusolmin, sponsored by Teva Pharmaceutical Industries Ltd. Started Oct 2024; status: completed.
02
Drugs
emrusolmin
Beyond the preview
Go deeper on NL-OMON58700.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58700.